Shenzhen Lifotronic Technology Co., Ltd. Stock

Equities

688389

CNE100005WZ5

Medical Equipment, Supplies & Distribution

End-of-day quote Shanghai S.E. 06:00:00 2024-04-25 pm EDT 5-day change 1st Jan Change
19.75 CNY +4.28% Intraday chart for Shenzhen Lifotronic Technology Co., Ltd. +13.12% -12.26%
Sales 2024 * 1.44B 198M Sales 2025 * 1.99B 275M Capitalization 8.11B 1.12B
Net income 2024 * 425M 58.66M Net income 2025 * 576M 79.5M EV / Sales 2024 * 5.64 x
Net cash position 2024 * - 0 Net cash position 2025 * - 0 EV / Sales 2025 * 4.07 x
P/E ratio 2024 *
19.1 x
P/E ratio 2025 *
14 x
Employees 1,481
Yield 2024 *
1.66%
Yield 2025 *
1.95%
Free-Float 45.72%
More Fundamentals * Assessed data
Dynamic Chart
1 day+0.74%
1 week+8.48%
Current month+4.70%
1 month+9.48%
3 months+0.74%
6 months+0.91%
Current year-15.86%
More quotes
1 week
17.22
Extreme 17.22
19.23
1 month
16.43
Extreme 16.43
19.23
Current year
14.00
Extreme 14
22.70
1 year
14.00
Extreme 14
28.44
3 years
12.02
Extreme 12.02
32.35
5 years
12.02
Extreme 12.02
40.96
10 years
12.02
Extreme 12.02
40.96
More quotes
Managers TitleAgeSince
Chief Executive Officer 55 13-12-31
Chairman 55 07-12-31
Director of Finance/CFO 58 10-12-31
Members of the board TitleAgeSince
Chief Executive Officer 55 13-12-31
Founder 56 08-01-15
Director/Board Member 55 12-12-31
More insiders
Date Price Change Volume
24-04-25 19.75 +4.28% 4 207 562
24-04-25 18.94 +0.74% 2,842,962
24-04-24 18.8 +1.18% 2,433,534
24-04-23 18.58 +4.79% 3,730,517
24-04-22 17.73 +1.14% 2,423,228

End-of-day quote Shanghai S.E., April 24, 2024

More quotes
Shenzhen Lifotronic Technology Co Ltd is a China-based company mainly engaged in the research, development, manufacturing and marketing of medical devices. The Company focuses on the development and technological innovation of treatment and rehabilitation equipment, in vitro diagnostic equipment and supporting detection reagents. The Company's products mainly include wound and skin treatment products, perioperative and intensive care products, pain and rehabilitation treatment products and in vitro diagnostic products. The Company mainly conducts its businesses in domestic and overseas markets.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
18.94 CNY
Average target price
25 CNY
Spread / Average Target
+32.00%
Consensus

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. 688389 Stock